University of Kentucky Joins the TriNetX Network to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs

Jun 8, 2016 | Press Releases

CAMBRIDGE, June 8, 2016 – TriNetX, a leader in international clinical research networks, announced today that the University of Kentucky (UK) signed a membership agreement to join the TriNetX network to optimize clinical trial design and advance clinical research for...

TriNetX Enters into Agreement with hict to Expand the TriNetX Network in Europe and the Middle East

Jun 3, 2016 | Press Releases

CAMBRIDGE, June 3, 2016 – TriNetX, a leader in international clinical research networks, announced today an agreement with hict, an independent healthcare consulting firm headquartered in Belgium, to expand the TriNetX network in Europe and the Middle East. The...

TriNetX Enters into Collaboration with Celgene Corporation to Advance Clinical Trial Design and Research for Next-Generation Medicines

May 24, 2016 | Press Releases

CAMBRIDGE, May 24, 2016 – TriNetX, a leader in international clinical research networks, today announced a collaboration with Celgene Corporation to advance clinical trial design and research for Celgene’s next-generation therapeutic programs. Celgene will gain real...

Ochsner Health System Partners with TriNetX, an International Research Data Network

May 18, 2016 | Press Releases

NEW ORLEANS, May 18, 2016 – Ochsner Health System announces its partnership with TriNetX, a leader in international clinical research data networks and a breakthrough disruptor of clinical trial design. Through this agreement, Ochsner clinicians will have improved...

Jefferson Joins the TriNetX Network to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs

May 10, 2016 | Press Releases

CAMBRIDGE, May 10, 2016 – TriNetX, a leader in international clinical research networks, announced today that Thomas Jefferson University signed a membership agreement to join the TriNetX network to optimize clinical trial design and advance clinical research for...

TriNetX Executes Agreement to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs

Mar 3, 2016 | Press Releases

CAMBRIDGE, March 3, 2016 – TriNetX, a leader in international clinical research networks, announced today the signing of a collaboration agreement with Novartis to optimize clinical trial design and advance clinical research for Novartis programs. Novartis researchers...